NDC 51672-1280-01 - Desonide
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 51672-1280
- Requested NDC
- 51672-1280-01
- Package NDCs from labels
- 51672-1280-1, 51672-1280-3, 51672-1280-01
- Manufacturer
- Sun Pharmaceutical Industries, Inc. | Sun Pharma Canada Inc. | Taro Pharmaceutical Industries Ltd.
- Effective date
- 2025-07-02
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Desonide Cream, 0.05% Desonide Ointment, 0.05% | Sun Pharmaceutical Industries, Inc. | Sun Pharma Canada Inc. | Taro Pharmaceutical Industries Ltd. | 2025-07-02 | HUMAN PRESCRIPTION DRUG LABEL |
| DESONIDE - Rebel Distributors Corp | Rebel Distributors Corp | 2011-05-23 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 51672-1280-1 | Desonide | 1 in 1 CARTON | CREAM | 1 | 9 | |
| 51672-1280-1 | Desonide | 15 g in 1 TUBE | CREAM | 15 | 9 | |
| 51672-1280-3 | Desonide | 1 in 1 CARTON | CREAM | 1 | 9 | |
| 51672-1280-3 | Desonide | 60 g in 1 TUBE | CREAM | 60 | 9 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 51672-1280 | DESONIDE CREAM DESONIDE OINTMENT [TARO PHARMACEUTICALS U.S.A., INC.] | 8 | Current NDC, Legacy NDC, 4 package rows | 20230202_6cea3912-23ae-45f3-b535-6fea29c7594f.zip |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 51672-1280-1 | GM - Gram | 51672-1280 | 7bb4bcb0-d929-4b4c-8b65-c4581204b76e | 1 | 2013-02-13 |
| 51672-1280-3 | GM - Gram | 51672-1280 | 5c3d95cf-3284-4daa-92c0-9c1b90268e3e | 1 | 2013-02-13 |
DailyMed Socrata Ingredients#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| White Rose Petroleum Jelly | PETROLATUM | J. Strickland & Co. | 1aeb090d-c103-4c2e-accc-d9d248315db9 | 2023-10-21 | Warnings | 4T6H12BN9U |
| Healquick Tattoo Balm | PETROLATUM | Unit Dose, Ltd. | 96f92c82-a79a-4d7e-ba0c-5ea67e2b6e86 | 2023-10-19 | Warnings | 4T6H12BN9U |
| Numpot Topical Anesthetic | LIDOCAINE, PETROLATUM | Unit Dose, Ltd. | 9143b50b-7d76-4545-aa2e-1bb77ffb44ae | 2023-10-19 | Warnings | 4T6H12BN9U |
| Liprotek | PETROLATUM, LIDOCAINE | Unit Dose, Ltd. | 051cfa27-bd7c-4f8c-b3e6-03ee0b7a3aa5 | 2023-10-19 | Warnings | 4T6H12BN9U |
| Numstick | PETROLATUM, LIDOCAINE | Unit Dose, Ltd. | 127bbd87-5402-4da2-abf3-dac6367735ec | 2023-10-18 | Warnings | 4T6H12BN9U |
| Eyeganics Organic Tears | GLYCERIN | Eyeganics LLC | 42470af7-a3ae-4e14-88e0-04cd92db4b37 | 2023-10-13 | Warnings | PDC6A3C0OX |
| Hemorrhoidal Pain Relief with Aloe and VitaminE | HEMORRHOIDAL PAIN RELIEF WITH ALOE AND VITAMINE | NeilMed pharmaceuticals Inc. | 076b5021-8ba0-0204-e063-6294a90a3337 | 2023-10-11 | Warnings | 4T6H12BN9U PDC6A3C0OX |
| Desonide | DESONIDE | NORTHSTAR RX LLC | bec5bd7f-2837-4767-8aa2-582cf58c6d2f | 2023-09-14 | Adverse reactions | ANDA074254 204135 J280872D1O |
| ANUBISMED | HA HYALURONIC | ANUBIS COSMETICS SL | eac771e2-4c1b-3808-e053-2995a90ac5fc | 2023-09-05 | Warnings | PDC6A3C0OX 059QF0KO0R |
| AnubisMed | SPF 50 BROAD SPECTRUM PROTECTION FLUID EMULSION | ANUBIS COSMETICS SL | e99d92c4-8768-9c0a-e053-2a95a90a609e | 2023-09-05 | Warnings | PDC6A3C0OX 059QF0KO0R |
| AnubisMed | AZELAIC ACID, SALICYLIC ACID | ANUBIS COSMETICS SL | ebf3153d-30f5-54e4-e053-2995a90a74b1 | 2023-09-05 | Warnings | 059QF0KO0R |
| AnubisMed | GLYCOLIC ACID, CITRIC ACID, LACTIC ACID, KOJIC ACID | ANUBIS COSMETICS SL | eca95dde-cb57-2ab6-e053-2995a90af84f | 2023-09-05 | Warnings | 059QF0KO0R |
| AnubisMed | SODIUM BICARBONATE, ALOE BARBADENSIS LEAF JUICE, IMIDAZOLIDINYL UREA | ANUBIS COSMETICS SL | ebf4b3ab-34e1-185a-e053-2a95a90ace3a | 2023-09-05 | Warnings | 059QF0KO0R |
| Lipotox | SQUALENE, CHOLESTERINUM, ESTRADIOL, PROGESTERONE, ASPARTAME, BENZALKONIUM CHLORIDE, FORMALINUM, METHYLENE CHLORIDE, METHYLPARABEN, PROPYLPARABEN, SODIUM BENZOATE, SODIUM CITRATE, TITANIUM DIOXIDE, ZINCUM OXYDATUM, ARSENICUM ALBUM, LYCOPODIUM CLAVATUM, NUX VOMICA, PHOSPHORICUM ACIDUM, PHOSPHORUS, ACETICUM ACIDUM, BENZOICUM ACIDUM, BENZYL ALCOHOL, BORICUM ACIDUM, CHLORINUM, CORTISONE ACETICUM, EUGENOL, FOLLICULINUM, ISOPROPYL PALMITATE, LACTICUM ACIDUM, PETROLEUM JELLY, PHENYL BUTAZONE, PLUMBUM METALLICUM, | BioActive Nutritional, Inc. | a1538692-ca00-4e52-9b7e-409767ee27e1 | 2023-09-05 | Warnings | 4T6H12BN9U A2I8C7HI9T |
| Anubis Barcelona | GLYCERIN, SORBITOL, ALOE BARBADENSIS LEAF JUICE | ANUBIS COSMETICS SL | eb651769-4d98-2b3b-e053-2a95a90a36b0 | 2023-09-01 | Warnings | PDC6A3C0OX 059QF0KO0R |
| Anubis Barcelona | DMAE | ANUBIS COSMETICS SL | f22b212d-d21d-5984-e053-2995a90a683e | 2023-09-01 | Warnings | PDC6A3C0OX 059QF0KO0R |
| Anubis Barcelona | DMAE, ZIRHAFIRM | ANUBIS COSMETICS SL | f2274f8c-08aa-eb02-e053-2a95a90a3998 | 2023-09-01 | Warnings | PDC6A3C0OX 059QF0KO0R 2DMT128M1S |
| Anubis Barcelona | PEG-40 HYDROGENATED CASTOR OIL, PROPYLENE GLYCOL, ALLANTOIN | ANUBIS COSMETICS SL | eb9244ea-6102-3cbe-e053-2a95a90ab8f6 | 2023-09-01 | Warnings | 059QF0KO0R A2I8C7HI9T |
| Anubis Barcelona | PROTEOGLYCAN, GLYCERIN, BUTYLENE GLYCOL | ANUBIS COSMETICS SL | ebdddcec-f5da-51fe-e053-2995a90a6167 | 2023-09-01 | Warnings | PDC6A3C0OX 059QF0KO0R |
| Anubis Barcelona Regul Oil | PROPYLENE GLYCOL, PANTHENOL, THIAMINE HCL | ANUBIS COSMETICS SL | eb8e5beb-4452-58c2-e053-2a95a90a66e0 | 2023-09-01 | Warnings | PDC6A3C0OX 059QF0KO0R A2I8C7HI9T |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.